Cergentis

0 Followers

About

Cergentis' Targeted Locus Amplification (TLA) Technology uniquely enables the targeted complete Next Generation Sequencing of any genomic locus in any genome of interest.

Max Van Min
Chief Scientific Officer
Erik Splinter
CTO
Harma Feitsma
Head of Business Development Oncology
Judith Bergboer
Head of Services
Marc Dijkstra
CFO
Georgios Georgiou
Head of Bioinformatics & Software Development

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.